Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes
Guy Jerusalem, Andree Rorive, Joelle Collignon Medical Oncology, CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, Liege, Belgium Abstract: Many systemic treatment options are available for advanced breast cancer, including endocrine therapy, chemotherapy, anti-human epidermal growth fa...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1f0e58e98d5e486282c90ca33f82886e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|